Open AccessLoculated Empyema and SARS-CoV-2 Infection: A Report of Two Cases and Review of the Literature
Author(s) -
Sarah Ayad,
Kirolos Gergis,
Sherif Elkattawy,
Noreen Mirza,
Basel Abdelazeem,
Latika Patel,
Carlos Remolina
Publication year - 2021
Publication title -
european journal of case reports in internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2284-2594
DOI - 10.12890/2021_002706
Subject(s) - medicine , empyema , parapneumonic effusion , pleural effusion , covid-19 , respiratory failure , disease , intensive care medicine , coronavirus , respiratory system , infectious disease (medical specialty) , surgery , pleural fluid
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical manifestations are diverse and can vary from mild respiratory symptoms to severe hypoxic respiratory failure. In severe cases, infection can cause gastrointestinal, renal, cardiac, neurological and haematological complications and result in multi-organ failure. There are very few reports of parapneumonic effusion in patients with COVID-19. We describe two patients with COVID-19 who had loculated empyema and discuss the clinical course and therapeutic options.